The Vanguard Group, Inc. recently announced the acquisition of new stake in Abercrombie & Fitch Co. (NYSE:ANF). The institutional investor has increased its shareholding in the Consumer Cyclical company by 2.37% to 6.07 million shares with purchase of 0.14 million shares. This fresh investment now brings its stake to 12.06% valued currently at $369.38 million. In addition, Fidelity Management & Research Co raised its holdings by 4.72 million to 4.76 million shares. And Marshall Wace LLP has lifted its position by 74.20% or 1.0 million shares – to 2.36 million shares.
With over 5.86 million Abercrombie & Fitch Co. (ANF) shares trading Tuesday and a closing price of $74.03 on the day, the dollar volume was approximately $433.85 million. The shares have shown a positive half year performance of 221.73% and its price on 11/21/23 gained nearly 2.41%. Currently, there are 49.00M common shares owned by the public and among those 48.86M shares have been available to trade.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
An analysis of what Wall Street brokers have to say about the expected price targets for this stock gives us this picture: 9 analysts who have offered their price forecasts for ANF have a consensus price objective of $69.83. The analysts have set the share’s price value over the next 12 months at a high of $85.00 and a low of $53.00. The average price target is -7.29% below its recent price level and a downside to the estimated low will see the stock lose -39.68% over that period. But an upside of 12.91% will see the stock hit the forecast high price target while median target price for the stock is $72.00.
Insiders at the company have transacted a total of 77 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 30 of these insider trades were purchases, accounting for 1,615,971 shares. Insider sales of the common stock occurred on 47 occasions, with total insider shares sold totaling 1,389,792 shares.
The top 3 mutual fund holders in Abercrombie & Fitch Co. are iShares Core S&P Small Cap ETF, Fidelity Blue Chip Growth Fund, and Vanguard Total Stock Market ETF. iShares Core S&P Small Cap ETF owns 3.37 million shares of the company’s stock, all valued at over $204.86 million. The company sold 11793.0 shares recently to bring their total holdings to about 6.69% of the shares outstanding. Fidelity Blue Chip Growth Fund bought 0.24 million shares to see its total holdings expand to 2.58 million shares valued at over $157.21 million and representing 5.13% of the shares outstanding. Vanguard Total Stock Market ETF bought 29197.0 shares to bring its total holdings to over 1.48 million shares at a value of $90.31 million. Vanguard Total Stock Market ETF now owns shares totaling to 2.95% of the shares outstanding.
Shares of Abercrombie & Fitch Co. (NYSE: ANF) opened at $70.22, down -$2.07 from a prior closing price of $72.29. However, the script later moved the day high at 74.77, up 2.41%. The company’s stock has a 5-day price change of 7.79% and 45.56% over the past three months. ANF shares are trading 223.13% year to date (YTD), with the 12-month market performance up to 294.20% higher. It has a 12-month low price of $18.31 and touched a high of $74.75 over the same period. ANF has an average intraday trading volume of 1.85 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 13.08%, 23.86%, and 87.00% respectively.
Institutional ownership of Abercrombie & Fitch Co. (NYSE: ANF) shares accounts for 111.33% of the company’s 49.00M shares outstanding. Mutual fund holders own 62.35%, while other institutional holders and individual stakeholders account for 7.31% and 50.97% respectively.
It has a market capitalization of $3.73B and a beta (3y monthly) value of 1.45. The stock’s trailing 12-month PE ratio is 18.50, while the earnings-per-share (ttm) stands at $4.00. The company has a PEG of 1.03 and a Quick Ratio of 0.82 with the debt-to-equity ratio at 1.27. Price movements for the stock have been influenced by the stock’s volatility, which stands at 6.07% over the week and 4.07% over the month.
Analysts forecast that Abercrombie & Fitch Co. (ANF) will achieve an EPS of $Can-Fite Biopharma Ltd Sponsore for the current quarter, $2.14 for the next quarter and $Stocks for Type. The lowest estimate earnings-per-share for the quarter is $FNF Group of Fidelity National while analysts give the company a high EPS estimate of $AutoNation, Inc.. Comparatively, EPS for the current quarter was $Sphere 3D Corp. a year ago. Earnings per share for the fiscal year are expected to increase by 1868.72%, and 4.52% over the next financial year. EPS should grow at an annualized rate of 18.00% over the next five years, compared to -11.66% over the past 5-year period.
If you are looking to buy this stock, then you may note that the average analyst recommendation by 9 brokerage firm advisors rate Abercrombie & Fitch Co. (ANF) as a “Moderate Buy” at a consensus score of 2.44. Specifically, 3 Wall Street analysts polled rate the stock as a buy, while 5 of the 9 advise that investors “hold,” and 0 rated it as a “Sell.”
Looking at the support for the ANF, a number of firms have released research notes about the stock. Morgan Stanley stated their Equal-Weight rating for the stock in a research note on August 25, 2023, with the firm’s price target at $18-$51.
